Vinci Gen S.A. (WSE:VGN)

Market Cap	3.31M
Revenue (ttm)	52.62K
Net Income (ttm)	69.77K
Shares Out	10.75M
EPS (ttm)	0.01
PE Ratio	47.44
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	42,035
Average Volume	67,766
Open	0.3160
Previous Close	0.3000
Day's Range	0.2920 - 0.3160
52-Week Range	0.2280 - 1.1850
Beta	0.36
RSI	54.47
Earnings Date	Nov 10, 2025

About Vinci Gen

Vinci Gen S.A. engages in the building and development of an integrated ecosystem of health services using modern genetics and imaging diagnostics in Poland, the European Union and global markets. Its areas of activity are NIPT prenatal diagnostics, genetic cancer diagnostics, artificial intelligence in diagnostics, telemedicine and mobile applications, medical marijuana and supportive therapies, and translational medicine and scientific cooperation. Vinci Gen S.A. was formerly known as Movie Games VR Spólka Akcyjna and changed its name to Vinc...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2010
• Employees: 1
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: VGN

Financial Performance

In 2023, Vinci Gen's revenue was 20,000, a decrease of -61.54% compared to the previous year's 52,000. Losses were -60,127, -65.56% less than in 2022.